Orchid Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1790.65

-39.25 (-2.14%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1790.65

-39.25 (-2.14%)
16:02 Dec 20

Quality

97/100
High Financial Strength

Valuation

18/100
Expensive Valuation

Technical

71/100
Technically Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	450.06	559.56	665.9	819.37	904.8
Operating Expenses +	400.28	506.43	582.27	708.7	777.66
Raw Material	245.6	340.62	406.1	528.35	598.58
Increase Decrease in Cost	-17.09	-27.06	-21.48	-43.89	-67.1
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	67.11	63.28	65.35	69.64	78.77
Miscellaneous Expenses	104.66	129.59	132.3	154.6	167.41
Operating Profit	49.78	53.13	83.63	110.67	127.14
Other Income	15.23	9	19.43	30.86	36.07
Depreciation	108.92	87.02	54.79	33.24	34.76
Interest	51.34	32.01	32.23	16.35	13.84
Profit before tax and exceptio..	-95.25	-56.9	16.04	91.95	114.61
Exceptional Items	0	0	39.21	0	0
PBT	-95.25	-56.9	55.25	91.95	114.61
Provision for Taxation	0	0	0	-3.12	-3.27
Net Profit	-116.53	1.57	48.47	95.06	117.86
NET Profit after MI	-116.53	-1.95	46.32	92.17	118.98
EPS	-28.55	-0.48	11.35	19.06	24.15
Operating Profit Margin (%)	11.06	9.5	12.56	13.51	14.05
Net Profit Margin (%)	-25.89	-0.35	6.96	11.25	13.15

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	69.80	69.80	69.80	69.80	72.40
FII	1.90	1.40	2.00	4.10	8.10
MF	16.80	16.90	15.20	10.40	9.80
Public	9.90	9.80	10.50	11.50	7.00
Others	0.10	0.00	0.00	0.10	0.10
Others	1.50	2.10	2.50	4.10	2.60